{"id":"https://openalex.org/W2600479727","doi":"https://doi.org/10.1200/jco.2014.32.15_suppl.9050","title":"Randomized, double-blind phase II trial of NY-ESO-1 ISCOMATRIX vaccine and ISCOMATRIX adjuvant alone in patients with resected stage IIc, III, or IV malignant melanoma.","display_name":"Randomized, double-blind phase II trial of NY-ESO-1 ISCOMATRIX vaccine and ISCOMATRIX adjuvant alone in patients with resected stage IIc, III, or IV malignant melanoma.","publication_year":2014,"publication_date":"2014-05-20","ids":{"openalex":"https://openalex.org/W2600479727","doi":"https://doi.org/10.1200/jco.2014.32.15_suppl.9050","mag":"2600479727"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2014.32.15_suppl.9050","doi":"https://doi.org/10.1200/jco.2014.32.15_suppl.9050","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2014.32.15_suppl.9050","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031661938","display_name":"Jonathan Simon Cebon","orcid":"https://orcid.org/0000-0002-3898-950X","observed_orcids":["https://orcid.org/0000-0002-3898-950X"]},"institutions":[{"id":"https://openalex.org/I4210123010","display_name":"Ludwig Cancer Research","ror":"https://ror.org/02vh2pt65","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I4210123010","https://openalex.org/I4210150094"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Jonathan S. Cebon","raw_affiliation_strings":["Ludwig Institute for Cancer Research, Melbourne, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ludwig Institute for Cancer Research, Melbourne, Australia","institution_ids":["https://openalex.org/I4210123010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048111860","display_name":"Grant A. McArthur","orcid":"https://orcid.org/0000-0001-8908-6071","observed_orcids":["https://orcid.org/0000-0001-8908-6071"]},"institutions":[{"id":"https://openalex.org/I2800555584","display_name":"Peter MacCallum Cancer Centre","ror":"https://ror.org/02a8bt934","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800555584"]},{"id":"https://openalex.org/I4405269164","display_name":"Peter MacCallum Cancer Foundation","ror":"https://ror.org/0395ye519","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I4405269164"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Grant A. McArthur","raw_affiliation_strings":["Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia","institution_ids":["https://openalex.org/I2800555584","https://openalex.org/I4405269164"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039692056","display_name":"Weisan Chen","orcid":"https://orcid.org/0000-0002-5221-9771","observed_orcids":["https://orcid.org/0000-0002-5221-9771"]},"institutions":[{"id":"https://openalex.org/I4210123010","display_name":"Ludwig Cancer Research","ror":"https://ror.org/02vh2pt65","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I4210123010","https://openalex.org/I4210150094"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Weisan Chen","raw_affiliation_strings":["Ludwig Insitute for Cancer Research, Heidelberg, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ludwig Insitute for Cancer Research, Heidelberg, Australia","institution_ids":["https://openalex.org/I4210123010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064732405","display_name":"Ian D. Davis","orcid":"https://orcid.org/0000-0002-9066-8244","observed_orcids":["https://orcid.org/0000-0002-9066-8244"]},"institutions":[{"id":"https://openalex.org/I4210098920","display_name":"Eastern Health","ror":"https://ror.org/00vyyx863","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210098920"]},{"id":"https://openalex.org/I56590836","display_name":"Monash University","ror":"https://ror.org/02bfwt286","country_code":"AU","type":"education","lineage":["https://openalex.org/I56590836"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Ian D. Davis","raw_affiliation_strings":["Monash University Eastern Health Clinical School, Box Hill, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Monash University Eastern Health Clinical School, Box Hill, Australia","institution_ids":["https://openalex.org/I4210098920","https://openalex.org/I56590836"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113897043","display_name":"Martin Eric Gore","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]},{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Martin Eric Gore","raw_affiliation_strings":["The Royal Marsden NHS Foundation Trust, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Royal Marsden NHS Foundation Trust, London, United Kingdom","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035263718","display_name":"John F. Thompson","orcid":"https://orcid.org/0000-0002-2816-2496","observed_orcids":["https://orcid.org/0000-0002-2816-2496"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]},{"id":"https://openalex.org/I2799732068","display_name":"Royal Prince Alfred Hospital","ror":"https://ror.org/05gpvde20","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2799732068"]},{"id":"https://openalex.org/I4210118383","display_name":"Melanoma Institute Australia","ror":"https://ror.org/02jxrhq31","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I4210118383"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"John F Thompson","raw_affiliation_strings":["Melanoma Institute Australia at Royal Prince Alfred Hospital, The University of Sydney, Sydney, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Melanoma Institute Australia at Royal Prince Alfred Hospital, The University of Sydney, Sydney, Australia","institution_ids":["https://openalex.org/I129604602","https://openalex.org/I2799732068","https://openalex.org/I4210118383"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079833339","display_name":"Michael Millward","orcid":"https://orcid.org/0000-0002-1744-1617","observed_orcids":["https://orcid.org/0000-0002-1744-1617"]},"institutions":[{"id":"https://openalex.org/I2802220196","display_name":"Sir Charles Gairdner Hospital","ror":"https://ror.org/01hhqsm59","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2799506148","https://openalex.org/I2800882159","https://openalex.org/I2802220196","https://openalex.org/I4210133657","https://openalex.org/I4396570646"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Michael Millward","raw_affiliation_strings":["Sir Charles Gairdner Hospital, Perth, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sir Charles Gairdner Hospital, Perth, Australia","institution_ids":["https://openalex.org/I2802220196"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082235252","display_name":"Michael P. N. Findlay","orcid":"https://orcid.org/0000-0002-3305-9768","observed_orcids":["https://orcid.org/0000-0002-3305-9768"]},"institutions":[{"id":"https://openalex.org/I154130895","display_name":"University of Auckland","ror":"https://ror.org/03b94tp07","country_code":"NZ","type":"education","lineage":["https://openalex.org/I154130895"]},{"id":"https://openalex.org/I4405267891","display_name":"Cancer Trials New Zealand","ror":"https://ror.org/04w0zw056","country_code":"NZ","type":"other","lineage":["https://openalex.org/I4405267891"]}],"countries":["NZ"],"is_corresponding":false,"raw_author_name":"Michael P. N. Findlay","raw_affiliation_strings":["Cancer Trials New Zealand, Discipline of Oncology, The University of Auckland, Auckland, New Zealand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Trials New Zealand, Discipline of Oncology, The University of Auckland, Auckland, New Zealand","institution_ids":["https://openalex.org/I154130895","https://openalex.org/I4405267891"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Rod Dunbar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154130895","display_name":"University of Auckland","ror":"https://ror.org/03b94tp07","country_code":"NZ","type":"education","lineage":["https://openalex.org/I154130895"]}],"countries":["NZ"],"is_corresponding":false,"raw_author_name":"Rod Dunbar","raw_affiliation_strings":["University of Auckland, Auckland, New Zealand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Auckland, Auckland, New Zealand","institution_ids":["https://openalex.org/I154130895"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072238075","display_name":"Christian H. H. Ottensmeier","orcid":"https://orcid.org/0000-0003-3619-1657","observed_orcids":["https://orcid.org/0000-0003-3619-1657"]},"institutions":[{"id":"https://openalex.org/I2802965805","display_name":"University Hospital Southampton NHS Foundation Trust","ror":"https://ror.org/0485axj58","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802965805"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Christian H.H Ottensmeier","raw_affiliation_strings":["Cancer Sciences Division, Southampton University Hospitals, Southampton, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Sciences Division, Southampton University Hospitals, Southampton, United Kingdom","institution_ids":["https://openalex.org/I2802965805"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007088159","display_name":"Ralph Rudolph Venhaus","orcid":"https://orcid.org/0000-0003-1106-8943","observed_orcids":["https://orcid.org/0000-0003-1106-8943"]},"institutions":[{"id":"https://openalex.org/I4210150094","display_name":"Ludwig Cancer Research","ror":"https://ror.org/05qdwtz81","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210150094"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ralph Rudolph Venhaus","raw_affiliation_strings":["Ludwig Institute for Cancer Research, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ludwig Institute for Cancer Research, New York, NY","institution_ids":["https://openalex.org/I4210150094"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085499539","display_name":"Paul Nathan","orcid":"https://orcid.org/0000-0002-2327-3250","observed_orcids":["https://orcid.org/0000-0002-2327-3250","https://orcid.org/0000-0002-5612-8439"]},"institutions":[{"id":"https://openalex.org/I2801038905","display_name":"Mount Vernon Hospital","ror":"https://ror.org/04am5a125","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799786270","https://openalex.org/I2801038905"]},{"id":"https://openalex.org/I4210108939","display_name":"Mount Vernon Cancer Centre","ror":"https://ror.org/01wwv4x50","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210108939","https://openalex.org/I4210122718"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Paul D. Nathan","raw_affiliation_strings":["Mount Vernon Cancer Centre, Northwood, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mount Vernon Cancer Centre, Northwood, United Kingdom","institution_ids":["https://openalex.org/I2801038905","https://openalex.org/I4210108939"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067606220","display_name":"Angus George Dalgleish","orcid":"https://orcid.org/0000-0003-3511-3059","observed_orcids":["https://orcid.org/0000-0003-3511-3059"]},"institutions":[{"id":"https://openalex.org/I165862685","display_name":"St George's, University of London","ror":"https://ror.org/040f08y74","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I165862685","https://openalex.org/I4401726869"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Angus George Dalgleish","raw_affiliation_strings":["St. George's University of London, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"St. George's University of London, London, United Kingdom","institution_ids":["https://openalex.org/I165862685"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000565081","display_name":"Vincenzo Cerundolo","orcid":"https://orcid.org/0000-0003-0040-3793","observed_orcids":["https://orcid.org/0000-0003-0040-3793"]},"institutions":[{"id":"https://openalex.org/I4210110594","display_name":"MRC Weatherall Institute of Molecular Medicine","ror":"https://ror.org/01q496a73","country_code":"GB","type":"facility","lineage":["https://openalex.org/I40120149","https://openalex.org/I4210087105","https://openalex.org/I4210110594","https://openalex.org/I90344618"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Vincenzo Cerundolo","raw_affiliation_strings":["Weatherall Institute of Molecular Medicine, Oxford, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Weatherall Institute of Molecular Medicine, Oxford, United Kingdom","institution_ids":["https://openalex.org/I4210110594"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056823066","display_name":"Eugene Maraskovsky","orcid":"https://orcid.org/0000-0003-3690-6253","observed_orcids":["https://orcid.org/0000-0003-3690-6253"]},"institutions":[{"id":"https://openalex.org/I4210153402","display_name":"CSL (Australia)","ror":"https://ror.org/044tc0x05","country_code":"AU","type":"company","lineage":["https://openalex.org/I4210153402"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Eugene Maraskovsky","raw_affiliation_strings":["CSL, Parkville, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CSL, Parkville, Australia","institution_ids":["https://openalex.org/I4210153402"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002075320","display_name":"Wendie Hopkins","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210123010","display_name":"Ludwig Cancer Research","ror":"https://ror.org/02vh2pt65","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I4210123010","https://openalex.org/I4210150094"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Wendie Hopkins","raw_affiliation_strings":["Ludwig Institute for Cancer Research, Melbourne, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ludwig Institute for Cancer Research, Melbourne, Australia","institution_ids":["https://openalex.org/I4210123010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109235510","display_name":"Jeremy R. Marsden","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jeremy Marsden","raw_affiliation_strings":["University of Birmingham, Birmingham, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Birmingham, Birmingham, United Kingdom","institution_ids":["https://openalex.org/I79619799"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018743654","display_name":"Bernard Mark Smithers","orcid":"https://orcid.org/0000-0002-8333-8685","observed_orcids":["https://orcid.org/0000-0002-8333-8685"]},"institutions":[{"id":"https://openalex.org/I2801814493","display_name":"Princess Alexandra Hospital","ror":"https://ror.org/04mqb0968","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I1302211766","https://openalex.org/I2801244131","https://openalex.org/I2801814493","https://openalex.org/I4210089726"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"B Mark Smithers","raw_affiliation_strings":["Princess Alexandra Hospital, Brisbane, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Princess Alexandra Hospital, Brisbane, Australia","institution_ids":["https://openalex.org/I2801814493"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055038393","display_name":"Peter Hersey","orcid":"https://orcid.org/0000-0002-3064-737X","observed_orcids":["https://orcid.org/0000-0002-3064-737X"]},"institutions":[{"id":"https://openalex.org/I4210118383","display_name":"Melanoma Institute Australia","ror":"https://ror.org/02jxrhq31","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I4210118383"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Peter Hersey","raw_affiliation_strings":["University of Newcastle, Newcastle and Melanoma Institute, Sydney, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Newcastle, Newcastle and Melanoma Institute, Sydney, Australia","institution_ids":["https://openalex.org/I4210118383"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5038656790","display_name":"Thomas R. Jeffry Evans","orcid":"https://orcid.org/0000-0002-4175-914X","observed_orcids":["https://orcid.org/0000-0002-4175-914X"]},"institutions":[{"id":"https://openalex.org/I2800373718","display_name":"Beatson West of Scotland Cancer Centre","ror":"https://ror.org/03pp86w19","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800373718"]},{"id":"https://openalex.org/I7882870","display_name":"University of Glasgow","ror":"https://ror.org/00vtgdb53","country_code":"GB","type":"education","lineage":["https://openalex.org/I7882870"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"T.R. Jeffry Evans","raw_affiliation_strings":["Beatson West of Scotland Cancer Centre, University of Glasgow, Glasgow, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beatson West of Scotland Cancer Centre, University of Glasgow, Glasgow, United Kingdom","institution_ids":["https://openalex.org/I2800373718","https://openalex.org/I7882870"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":24,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"32","issue":"15_suppl","first_page":"9050","last_page":"9050"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.6547999978065491,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.6547999978065491,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.33640000224113464,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.004999999888241291,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ny-eso-1","display_name":"NY-ESO-1","score":0.9710000157356262},{"id":"https://openalex.org/keywords/cancer-testis-antigens","display_name":"cancer-testis antigens","score":0.8180000185966492},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.878000020980835},{"id":"https://openalex.org/keywords/cancer-vaccines","display_name":"cancer vaccines","score":0.5460000038146973},{"id":"https://openalex.org/keywords/adjuvant-immunotherapy","display_name":"adjuvant immunotherapy","score":0.8309999704360962},{"id":"https://openalex.org/keywords/relapse-free-survival","display_name":"relapse-free survival","score":0.8700000047683716},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.824999988079071},{"id":"https://openalex.org/keywords/cell-mediated-immunity","display_name":"cell-mediated immunity","score":0.8629999756813049},{"id":"https://openalex.org/keywords/vaccine-safety","display_name":"vaccine safety","score":0.4410000145435333},{"id":"https://openalex.org/keywords/stage-iv-melanoma","display_name":"stage IV melanoma","score":0.5090000033378601},{"id":"https://openalex.org/keywords/immunotherapy-targets","display_name":"immunotherapy targets","score":0.4300000071525574},{"id":"https://openalex.org/keywords/relapse-prevention","display_name":"relapse prevention","score":0.3610000014305115}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8417523503303528},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.7868300676345825},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.6518034338951111},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.6377817392349243},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5164477825164795},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.5121173858642578},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.49099496006965637},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4341241419315338},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3994691073894501},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.39079320430755615},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.34929147362709045},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.10792109370231628},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2014.32.15_suppl.9050","doi":"https://doi.org/10.1200/jco.2014.32.15_suppl.9050","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2014.32.15_suppl.9050","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3010572614","https://openalex.org/W591676439","https://openalex.org/W7033663930","https://openalex.org/W2805597841","https://openalex.org/W2036539860","https://openalex.org/W2890141609","https://openalex.org/W2128564429","https://openalex.org/W2605202598","https://openalex.org/W2890617997","https://openalex.org/W2116487491"],"abstract_inverted_index":{"9050":[0],"Background:":[1],"The":[2,310],"cancer":[3,18],"testis":[4],"antigen":[5],"NY-ESO-1":[6],"(ESO)":[7],"has":[8],"been":[9],"evaluated":[10],"as":[11],"a":[12,15,23,60,94,244,256,290],"biomarker":[13],"and":[14,30,112,129,145,169,174,226,296,320],"therapeutic":[16],"immunologic":[17],"target.":[19],"Preliminary":[20],"data":[21],"from":[22],"phase":[24,63],"I":[25],"clinical":[26],"trial":[27,341],"of":[28,103,119,123,137,232,248,275,280,283,305],"ESO":[29,54,81,86,146,166,252,267,311],"ISCOMATRIX":[31],"adjuvant":[32,57,89,172],"(ESO":[33],"vaccine)":[34],"suggested":[35],"this":[36,269],"treatment":[37],"could":[38],"prevent":[39],"relapse":[40,211,327],"in":[41,59,66,107,250],"patients":[42],"(pts)":[43],"with":[44,68,71,153,161,336],"high":[45],"risk":[46],"resected":[47,72],"malignant":[48],"melanoma":[49,79],"(MEL).":[50],"Methods:":[51],"We":[52],"compared":[53],"vaccine":[55,87,167,253,312],"to":[56,85,164,171,204,222,266],"alone":[58],"randomized":[61,83,163],"double-blind":[62],"II":[64],"study":[65],"pts":[67,151,249,286],"MEL.":[69],"Pts":[70],"stage":[73,179],"IIc,":[74],"IIIb,":[75],"IIIc,":[76],"or":[77,88,210],"IV":[78],"expressing":[80],"were":[82,177,184,234,300],"1:1":[84],"x3":[90],"q4w":[91],"followed":[92],"by":[93],"4th":[95],"dose":[96],"at":[97,105,178,181,302],"6m.":[98],"Primary":[99],"endpoint":[100],"was":[101,313],"rate":[102],"RFS":[104,128,225],"18m":[106,198,306],"the":[108,134,158,165,189,193,197,229,237,241,251,273,276,284,303],"intent-to-treat":[109],"(ITT)":[110],"population":[111,195],"two":[113,190,238],"per":[114],"protocol":[115],"(PP)":[116],"populations,":[117],"consisting":[118],"all":[120],"relapses":[121],"regardless":[122],"location.":[124],"Secondary":[125],"objectives":[126],"included":[127],"Overall":[130],"Survival":[131],"(OS)":[132],"over":[133],"entire":[135,230],"period":[136,200,231],"observation":[138,199,233],"(study":[139],"defined":[140],"plus":[141],"off-study":[142],"follow-up),":[143],"safety":[144],"immunity.":[147],"Results:":[148],"Of":[149],"111":[150],"screened":[152],"ESO-expressing":[154],"MEL,":[155],"110":[156],"comprised":[157],"ITT":[159,194],"population,":[160],"56":[162],"arm":[168,254],"54":[170],"(96%":[173],"87%,":[175],"respectively,":[176],"\u2265IIIa":[180],"entry).":[182],"There":[183],"no":[185,297],"significant":[186],"differences":[187],"between":[188,236],"arms":[191],"for":[192,201,228,272],"during":[196],"median":[202],"time":[203],"relapse,":[205],"139":[206],"vs":[207,215],"176":[208],"days(p=0.296),":[209],"rate,":[212],"27":[213],"(48.2%)":[214],"26":[216],"(48.1%)":[217],"(HR=0.913;":[218],"95%":[219],"CI,":[220],"0.402":[221],"2.231),":[223],"respectively.":[224],"OS":[227],"similar":[235],"arms.":[239],"After":[240],"third":[242],"immunization,":[243],"significantly":[245],"larger":[246],"percentage":[247],"developed":[255],"strong":[257,318],"positive":[258],"antibody":[259],"(Ab)":[260],"&":[261],"cellular":[262,321],"immune":[263],"response":[264],"(IR)":[265],"(p<0.001);":[268],"difference":[270],"remained":[271],"duration":[274],"study.":[277,308],"A":[278],"total":[279],"17":[281],"out":[282],"31":[285],"(55%)":[287],"who":[288],"had":[289],"vaccine-induced":[291],"IR":[292],"(Ab":[293],"against":[294],"ESO)":[295],"pre-existing":[298],"immunity":[299],"relapse-free":[301],"end":[304],"on":[307],"Conclusions:":[309],"safe,":[314],"well":[315],"tolerated,":[316],"elicited":[317],"Ab":[319],"responses":[322],"but":[323],"did":[324],"not":[325],"affect":[326],"free":[328],"survival.":[329],"Optimal":[330],"efficacy":[331],"may":[332],"require":[333],"combining":[334],"it":[335],"other":[337],"immunotherapy":[338],"modalities.":[339],"Clinical":[340],"information:":[342],"NCT00199901.":[343]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":1}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2017-04-07T00:00:00"}